MDONCSAMPLES

Page 1


MY CARE PLUS

Introducing a New Convenient Way to Connect: Online! The Message Center is a new feature that allows you to securely communicate with your care team through the online portal, My Care Plus . SM

You may use the Message Center for non-urgent* topics like: • • • •

Scheduling appointments and cancellations Diagnostics preparation Questions about lab results Non-urgent medication questions

To use the Message Center, enroll in My Care Plus by completing and submitting the consent form at the front desk. * For urgent matters, contact our office or call 911.

www.MyCarePlusOnline.com


My Care Plus Instructions To send and receive messages through the Message Center: 1. Log in to My Care Plus www.MyCarePlusOnline.com

1

2

2. Click the Message Center link

To send a message: 3. Click Compose Message from the menu 4. Select your doctor, enter your subject and message, and click Send

To view and reply to your received messages: • Click the Inbox link • Click anywhere on the message to open and read

3

• U se the Reply Message box at the bottom to enter your message, and click Reply

If you have questions regarding enrollment in My Care Plus, please contact our office. If you need assistance with the Message Center, please contact My Care Plus Support by email at Support@MyCarePlusOnline.com or call 855.887.6788. www.MyCarePlusOnline.com

• Your care team will make every attempt to respond to your messages quickly, but some responses may take up to 48 hours.

• A staff member, such as a nurse or administrative staff, may respond to your message on behalf of your doctor.

• Do not use the Message Center for emergencies.

www.MyCarePlusOnline.com The US Oncology Network is supported by McKesson Specialty Health. © 2014 McKesson Specialty Health. All rights reserved.

4


HAVE A QUESTION FOR US? Use the Message Center to connect with us today! For urgent matters, contact our office or call 911.

www.MyCarePlusOnline.com

The US Oncology Network is supported by McKesson Specialty Health. Š 2014 McKesson Specialty Health. All rights reserved.


MY CARE PLUS: MESSAGE CENTER

A NEW WAY TO CONNECT

Introducing the My Care Plus Message Center A secure way to send us non-urgent* messages at your convenience. Ask for details to get started, and we’ll be happy to help. * Do not use the Message Center for emergencies.

www.MyCarePlusOnline.com

The US Oncology Network is supported by McKesson Specialty Health. © 2014 McKesson Specialty Health. All rights reserved.


Cloverly 200

Aspen Hill

Burtonsville

95

7350 VAN DUSEN ROAD, STE. 370 LAUREL, MD 20707

Colesville 1 95

12210 PLUM ORCHARD DR, STE. 211 SILVER SPRING, MD 20904

Wheaton Glenmont

2730 UNIVERSITY W BLVD, STE. 400 SILVER SPRING, MD 20902

White Oak

Beltsville

193

Adelphi

495 29

7525 GREENWAY CENTER DRIVE, STE 205 GREENBELT, MD 20770 1

Silver Spring

College Park


MyCarePlusOnline.com

My Care Plus:

Get secure, convenient access to information about your diagnosis, lab results, medications and more.

Enroll Today! We are pleased to offer you this valuable service providing you online access to your Personal Health Record. Simply tell our staff you’re interested, and we’ll help you get started.


G enetic C ounseling -R eferral C riteria APPROXIMATELY 10% OF ALL CANCERS ARE HEREDITARY

H ereditary B reast

and

O varian C ancer

REFER PATIENTS THAT MEET ANY OF THE FOLLOWING CRITERIA:

❑ ❑ ❑ ❑ ❑ ❑ ❑

Breast Cancer under age 50 Bilateral Breast Cancer Ovarian Cancer at any age Male breast cancer in patient or family member Ashkenazi Jewish Ancestry with Personal or Family History of Breast/Ovarian Cancer > 2 Close Blood Relatives with Breast Cancer and/or Ovarian Cancer Triple Negative (ER-, PR-, HER2-) Breast Cancer < 60 Breast Cancer includes DCIS and Invasive Cancers.

O ther C riteria ❑ Bilateral or multiple primary cancers ❑ Rare tumors such as medullary thyroid carcinoma, paragangliomas or pheochromocytomas ❑ Known gene mutation in family

H ereditary C olon C ancer REFER PATIENTS THAT MEET ANY OF THE FOLLOWING CRITERIA:

❑ Colorectal (CRC) Cancer < 50 years ❑ Colon Cancer < 60 years with MSI-H histology (tumor infiltrating lymphocytes, Crohn’s like lymphocytic reaction, mucinous/signet-ring differentiation, or medullary growth pattern) ❑ Two or more primary CRC’s or Lynch related tumors* ❑ > 3 Family members, same side of the family, with CRC, Uterine, Ovarian or other Lynch related tumors ❑ > 10 GI Adenomas (pre-cancerous polyps) ❑ Multiple Hamartomatous (Juvenile) GI Polyps *Uterine, Ovarian, Gastric, Pancreatic, Urinary Tract, Sebaceous Tumor, and Brain Tumors

The initial appointment at MOH involves a consult with a medical oncologist Columbia • Silver Spring • Greenbelt • Laurel • Owings Mills • Gettysburg, PA www.MDOnc.com


Maryland_Cancer101_Press_2712.pdf 1 2/7/2012 12:30:58 PM

PATIENT PLANNER B A S I C S F O R T H E N E WLY DIAGN OSE D

A P L AN N E R F OR P E OP L E WI T H CANCE R AND THE I R CAR E G I V E R S

www.M D ONC.c om


Maryland_Cancer101_Press_2712.pdf 2 2/7/2012 12:30:59 PM

Columbia Silver Spring Greenbelt

Our mission is to deliver on the promise of providing the best patient care possible in a caring and supportive environment; with

Laurel

seamless access to the latest in technology

Owings Mills

and research available to help every patient

Gettysburg, PA

live their highest quality of life.


MARCH IS COLORECTAL CANCER AWARENESS MONTH

Don’t be Chicken

Get Screened Today. Diets high in red or processed meat can increase the risk of developing colorectal cancer. Screening for colorectal cancer can find polyps early, before they turn into cancer. Screening tests available include a colonoscopy, imaging scans and blood tests. While most people should begin screening at age 50, if you are at increased risk of developing colorectal cancer, speak with your doctor about the benefits of screening earlier, having additional tests or having more frequent exams. Also, report to your doctor any change in your bowel habits, such as diarrhea, constipation, narrower than-usual stool, blood in your stool, or frequent gas or cramps. Risk Factors for Colorectal Cancer: • Age over 50 • History of colorectal polyps or colorectal cancer • History of inflammatory bowel disease • Family history of colorectal cancer • Obesity

• • • • •

African American or Jewish of Eastern European decent A diet that is high in red and/or processed meats Physical inactivity Smoking Type 2 Diabetes

Kashif Ali, MD • Thomas A. Bensinger, MD, FACP • Alida Espinoza, MD Kashif Firozvi, MD • Frederick Min, MD • Martin D. Weltz, DO, FACP, MBA, MPH Greenbelt 7525 Greenway Center Drive Suite 205 Greenbelt, MD 20770 (301) 982-9800 www.MDOnc.com

Laurel 7350 Van Dusen Road Suite 370 Laurel, MD 20707 (301) 982-9800

Silver Spring 2101 Medical Park Drive Suite 200 Silver Spring, MD 20902 (301) 933-3216


MOH_Pikesville_Growth_OpenHouseFlyer_outlines.indd 1

4/20/2012 5:06:59 PM


MOH_Pikesville_Growth_OpenHouseFlyer_outlines.indd 2

4/20/2012 5:07:02 PM



We are Proud to Announce our new

LOCATION

Westminster

MOH_Westminster_Growth_Flyer.indd 1

5/21/2012 5:08:36 PM


w e hav e a ne w

westminster address

Maryland Oncology Hematology is pleased to announce we have opened a new office in Westminster. We remain committed to providing the best oncology and hematology services in a community setting close to home. In our new state of the art infusion center, we offer today’s most effective therapies, expertly and compassionately delivered.

our new address 680 Poole Road Westminster, MD 21157 To refer a patient, please call (410) 581-2100

Mohit Narang, MD

MOH_Westminster_Growth_Flyer.indd 2

MDONC.COM

Robert RICE, MD, PhD

5/21/2012 5:08:46 PM


Providing comprehensive, compassionate care.

Our dedicated physicians, nurses and staff provide a full range of cancer care services including chemotherapy, laboratory testing, clinical trials and support services. We are united in healing with The US Oncology Network, one of the nation’s largest communitybased cancer treatment and research networks dedicated to expanding patient access to high-quality care.

Mohit Narang, MD

Robert Rice, MD, PhD

Manoj Agarwal, MD, MBA

Medical Oncology & Hematology

Medical Oncology & Hematology

Medical Oncology & Hematology

Pikesville • 1838 Greene Tree Rd., Suite 260 • Pikesville, MD 21208 • (410) 581-2100 Westminster • 680 Poole Rd., Suites A & B • Westminster, MD 21157 • (410) 581-2100 Gettysburg • 40 V Twin Dr., Suite 104 • Gettysburg, PA 17325 • (717) 338-9009

www.mdonc.com

12071902.indd 1

7/24/12 1:41 PM


Celebration of Life Gathering Please join us in celebrating the life and times of

Clement B. Knight, M.D. Friends, colleagues, and patients are invited to celebrate the memories of a life well-lived. August 30, 2012 4-7 pm Maryland Oncology Hematology 10710 Charter Dr G020 Columbia, Maryland 21044 Donations can be made in honor of Clement B. Knight, M.D to the Clement B. Knight, M.D. Patient Assistance Fund C/o Maryland Oncology Hematology, P.A.


2730 University W Blvd. Suite 400 Wheaton, MD 20902


Cheryl A. Aylesworth, M.D. Linda M. Burrell, M.D.

Maryland Oncology Hematology, P.A. 2730 University W Blvd., Suite 400 Wheaton, MD 20902 phone (301) 942-9220 fax (301) 942-9223 www.mdonc.com

October 2012

Dear Colleague, We are pleased to inform you that we have joined the talented physician team of Maryland Oncology Hematology, P.A. By joining Maryland Oncology Hematology, we are able to provide our patients with expanded access to the latest treatment therapies and increased opportunities to participate in ground-breaking clinical trials while continuing to provide the same exceptional care our patients have come to expect. Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America. As an affiliate of The US Oncology Network, we are able to collaborate with the 13 other physicians of Maryland Oncology Hematology, as well as approximately 1,000 physicians nationwide. We will continue to see patients at our Wheaton location: 2730 University W Blvd., Suite 400 Wheaton, MD 20902 Phone: (301) 942-9220 In early 2013, we will be relocating from our Wheaton office listed above to 2101 Medical Park Drive, Suite 200, Silver Spring, MD 20902. At our Silver Spring location, we will be able to provide a comprehensive cancer care experience to our patients coupled with consolidated radiation and imaging services. We will also be exploring opportunities for clinic hours in Greenbelt and Laurel. Please feel free to let the front desk staff know if this is of interest to you. Our privileges include hematology and oncology at Holy Cross, MGH and Suburban hospitals. Privileges are pending at WAH. Most insurance plans are accepted. We are excited to continue to bring expert cancer care to our patients and their families. Our first priority is, and will always be, our patients. We appreciate your trust and confidence and look forward to our continued relationship. Sincerely,

Cheryl A. Aylesworth, M.D.

Linda M. Burrell, M.D.


JOINING FORCES IN THE FIGHT.

Maryland Oncology Hematology is pleased to announce the addition of Cheryl A. Aylesworth, M.D. and Linda M. Burrell, M.D. to our physician staff. 12091804.indd 1

11/1/12 10:52 AM


E X P E RT P H Y S I C I A N S . EXCEPTIONAL CARE.

2730 University W Blvd. Suite 400 Wheaton, MD 20902

At Maryland Oncology Hematology, we believe the best care is both advanced and compassionate. Our philosophy is to care for the whole person, not just fight the disease. We are proud to welcome Dr. Cheryl A. Aylesworth and Dr. Linda M. Burrell to our team of board certified physicians. Together, we will continue to provide patients with the latest cutting-edge treatments and options in their fight against cancer. Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks dedicated to expanding patient access to high-quality care. Dr. Aylesworth and Dr. Burrell will continue to see patients at their Wheaton Location: 2730 University W Blvd. Suite 400 Wheaton, MD 20902 Phone: (301) 942-9220 Fax: (301) 942-9223

Cheryl A. Aylesworth, M.D.

Linda M. Burrell, M.D.

www.MDOnc.com

12091804.indd 2

11/1/12 10:52 AM


It is with profound sadness and heavy hearts, we remember our dear friend and colleague, Clement B. Knight, M.D., who passed on August 9, 2012. Those of us who were fortunate to know Clement have lost a dear friend, colleague and an outstanding physician. No words can adequately express our sadness at his passing or our gratitude for the opportunity to have worked with him.

Clement B. Knight, M.D.

www.mdonc.com

The Physicians and Staff of Maryland Oncology Hematology, P.A.


Providing comprehensive, compassionate care. Our dedicated physicians, nurses and staff provide individualized wellness plans for patients with access to a full range of cancer care services including chemotherapy, laboratory testing, clinical trials and support services. We are united in healing with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks dedicated to expanding patient access to high-quality care.

Silver Spring 301-933-3216

Greenbelt/Laurel 301-982-9800

Wheaton 301-942-9220

Kashif Ali, M.D. Roopa De Chowdhury, M.D. Alida Espinoza, M.D. Kashif Firozvi, M.D. Frederick Min, M.D. Kristin Sorenson, NP-C, MS, RN

Kashif Ali, M.D. Thomas A. Bensinger, M.D., F.A.C.P. Roopa De Chowdhury, M.D. Alida Espinoza, M.D. Ayana M. Elliott, D.N.P., C.R.N.P.

Cheryl Aylesworth, M.D. Linda Burrell, M.D.

www.mdonc.com


Physician Contact Card Medical Oncology and Hematology

Thomas A. Bensinger, MD, FACP 301-717-5758

Kashif Firozvi, MD 202-210-8633

Frederick Min, MD 202-744-7921

Alida Espinoza, MD 443-629-8499

Thomas.Bensinger@usoncology.com Greenbelt

Kashif.Firozvi@usoncology.com Silver Spring

David.Min@usoncology.com Silver Spring

Alida.Espinoza@usoncology.com Silver Spring & Greenbelt

Kashif Ali, MD 410-404-2500

Roopa DeChowdhury, MD 202-550-9222

Cheryl A. Aylesworth, MD 301-802-0231

Linda M. Burrell, MD 301-801-5951

Kashif.Ali@usoncology.com Silver Spring, Greenbelt & Laurel

Roopa.DeChowdhury@usoncology.com Silver Spring, Greenbelt & Laurel

Cheryl.Aylesworth@usoncology.com Wheaton

Linda.Burrell@usoncology.com Wheaton


Services

We See Patients At:

• Physician evaluation and treatment planning

• Holy Cross Hospital

for blood disorders and cancer care

• Washington Adventist Hospital

• Second opinion services

• Suburban Hospital

• Chemotherapy and infusion therapy

• Laurel Regional Hospital

• Therapeutic phlebotomies

• Doctors Community Hospital

• Maintenance of IV devices • Laboratory services by a state accredited lab • Bone marrow biopsies • Administration of injections for the treatment of cancer and hematological disorders • Access to complementary and alternative medicine

Greenbelt

Silver Spring

Wheaton

Laurel

7525 Greenway Center Drive Suite 205 Greenbelt, MD 20770 301-982-9800

2101 Medical Park Drive Suite 200 Silver Spring, MD 20902 301-933-3216

2730 University W Blvd. Suite 400 Silver Spring, MD 20902 301-942-9220

7350 Van Dusen Road Suite 370 Laurel, MD 20707 301-982-9800

www.MDONC.com


What is Patient Assistance Support? • Patient Assistance Support (PAS) consists of a team of specialists that work in collaboration with our financial counselors to explore and provide access to the best funding options available for your diagnosis and treatment. • PAS is offered to you free of charge to connect you to a range of support, tailored to your situation:

The cost of cancer care can be overwhelming…

a

Contact Us Today PAS Representative: 866.744.8766

✓✓ Do you have insurance with a co-pay for medications? ✓✓ Do you use Medicare? ✓✓ Do you have limited coverage or no health insurance at all? ✓✓ Do you seek support even though you may think you are “over income”? We estimate income guidelines for you.

Seeking financial assistance doesn’t have to be.

…PAS can help! Patient Assistance Support is offered to our patients in collaboration with The US Oncology Network and McKesson Specialty Health – providing the advanced care you’d expect from one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America.

© 2013 McKesson Specialty Health. All rights reserved.

PATIENT ASSISTANCE SUPPORT


You’re not alone in your search for financial assistance.

Tips for getting started.

1

SCHEDULE A PERSONAL CONSULTATION WITH OUR FINANCIAL COUNSELOR

• Simply call our office to set up a free consultation with a financial counselor/patient benefit representative. He/she can help you determine the type of budgeting support or financial assistance you may need based on the extent of your health insurance coverage and the length and type of your prescribed cancer treatment plan.

Battling cancer can be daunting enough without having to worry about the affordability of care. We work with manufacturers and community organizations to help qualified patients obtain financial assistance to enable them to get the care they need. You may have questions about the cost of your treatment and how much your insurance will cover. We understand how quickly out-of-pocket expenses can add up, which is why we are pleased to extend Patient Assistance Support (PAS) at no charge to you. PAS can help you to navigate the financial aspects of your care plan and evaluate assistance options that may help with your cancer care costs.

• The counselor/ patient benefit representative will collaborate with your physician to suggest ways to reduce medical and associated costs and assign you a PAS specialist with knowledge of the support services that may be available to address your situation. • To make the most of your cost-of-care consultation and uncover all options, please come prepared with the following:

✓✓ A list of your concerns and questions regarding your insurance benefits or your ability to cover your costs ✓✓ The most recent benefits statement from your insurer ✓✓ All insurance cards, including insurance or discount cards for hospital and prescription costs ✓✓ A friend or family member to support you

2

LET PAS ASSIST YOU WITH THE FINANCIAL APPLICATION PROCESS

Once you have completed your financial consultation and it is determined that seeking financial support is a good option for you, a PAS specialist can guide you through the process of applying for assistance through non-profit organizations or manufacturer assistance programs. PAS will recommend a variety of resources available that are applicable to you. If you would like PAS to assist you with processing applications, you will simply need to: 1. Sign a form provided by your financial counselor authorizing PAS to complete applications on your behalf. 2. Provide recent proof of income (e.g., federal tax return, social security award letter, bank statement, etc.). 3. Be available on occasion to work with PAS to finalize the applications (e.g., provide signatures, confirm information) and respond to follow-up requests from the various programs.

We’re here to help! Call us at any time with questions or concerns about your financial situation.

PAS REPRESENTATIVE: 866.744.8766 (toll free)


The Compassion to Care. The Knowledge to Heal. 2730 University W. Blvd., Suite 400 • Silver Spring, MD 20902 • 301-942-9220 2101 Medical Park Drive, Suite 200 • Silver Spring, MD 20902 • 301-933-3216 7350 Van Dusen Road, Suite 370 • Laurel, MD 20707 • 301-982-9800 7525 Greenway Center Drive, Suite 205 • Greenbelt, MD 20770 • 301-982-9800


Entrusting your patients' care to Maryland Oncology Hematology is greatly appreciated.


BLADDER CANCER FACTS Bladder cancer incidence is about four times higher in men than in women. When found early, the chance of survival is greater. Since the 1980s, the survival rate has increased due to improved awareness and better treatments options.

Risk factors Smoking: Smoking is the greatest risk factor for bladder caner; damaging chemicals from tobacco can enter the blood stream, through the lungs, and are filtered by the liver and collect in the bladder Chemical exposure: Some professions are regularly exposed to harmful chemicals which can lead to increased risk Race: Caucasians are twice more likely to develop bladder cancer than African Americans or Hispanics Gender: Men develop bladder cancer four times as often as women Age: The risk of developing bladder cancer increases with age Family history: There is an increased risk when immediate family members have the disease Chronic bladder inflammation: Urinary infections, kidney stones and bladder stones do not cause cancer, but they are linked to the disease Arsenic: This chemical in drinking water is linked to an increased risk of bladder cancer

Signs and symptoms If a patient experiences any of these symptoms they should consult a physician. Blood in urine Frequent urination or feeling the need to urinate


Screening Screening tests can determine the presence of abnormal cells in the bladder. There are various ways to screen for bladder cancer. Each method may be used alone, or in combination: Cystoscopy, which allows a physician to view the inside of the bladder through a small tube with a lens and a light; the physician may perform a biopsy at this time Urine cytology, which tests the urine or cells “washed� from the bladder Urine culture, which involves testing the urine Imaging tests, which allows the doctors to better see your bladder and provide more information

Treatment If abnormal cells are present, the patient will be referred to an oncologist who will conduct a biopsy and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more

For more information, visit MDOnc.com

The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.


LEUKEMIA CANCER FACTS

Leukemia is a cancer of the bone marrow and blood and is classified into four main groups according to cell type and rate of growth. Almost 90% of leukemia cases are diagnosed in adults 20 years of age and older.

Risk factors Radiation exposure: Exposure to ionizing radiation increases the risk of leukemia Family history: There is an increased risk when immediate family members have the disease Age: The majority is found in adults over the age of 20 Chemical exposure: Exposure to certain chemicals can increase the chances of developing leukemia Gender: Leukemia is more common in men than women

Signs and symptoms If a patient experiences any of these symptoms they should consult a physician. Fatigue or tiring more easily Fever Bruising easily Weight Loss Swollen belly Night sweats


Screening To diagnose and classify leukemia, a physician may conduct the following: Blood tests allow a physician to review the number of blood and/or marrow cells and look at the shape of chromosomes Bone marrow biopsy allows physicians to screen for abnormal cells

Treatment If cancer is suspected, the patient will be referred to an oncologist who will conduct tests and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more

For more information, visit MDOnc.com

The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.


NON-HODGKIN LYMPHOMA CANCER FACTS Lymphoma is cancer of the lymphocytes, a type of white blood cell. There has been a decline in the number of deaths resulting from lymphoma due to improvements in treatment options.

Risk factors Age: The majority is found in adults over the age of 60 Chemical exposure: Exposure to certain chemicals can increase the chances of developing lymphoma Gender: Men are more likely to develop lymphoma than women Race: Caucasian individuals have greater incidence and death rates Immune system deficiency: Individuals with weakened immune systems are at increased risk

Signs and symptoms If a patient experiences any of these symptoms they should consult a physician. Swollen lymph nodes Itching Night sweats Fatigue or tiring more easily Swollen belly


Screening To diagnose lymphoma, a physician may conduct the following biopsies: Excisional or incisional biopsy allows a physician to determine the exact type of lymphoma by examining a sample removed from the patient Bone marrow biopsy allows a physician to withdraw a small amount of tissue using a thin, hollow needle

Treatment If cancer is suspected, the patient will be referred to an oncologist who will conduct tests and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more

For more information, visit MDOnc.com

The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.


OVARIAN CANCER FACTS According to the American Cancer Society, ovarian cancer accounts for approximately 3% of all cancers among women. While incidence rates continue to decline, the disease usually has no obvious symptoms.

Risk factors Family history: The most important risk factor is strong family history of breast or ovarian cancer Age: Most ovarian cancers develop after menopause and half are found in women over the age of 63 Obesity: A higher rate of death from ovarian cancer is found in obese women Reproductive history: Women who began menstruating before 12, had no children or had their first child after 30, and/or experienced menopause after 50 may have an increased risk Fertility drugs: Prolonged use of the fertility drug clomiphene citrate, especially without achieving pregnancy, may increase risk Breast cancer: Women with BRCA mutation have an increased risk

Signs and symptoms The signs of ovarian cancer are usually relatively vague, including: Abnormal swelling of the stomach Unusual vaginal bleeding Pelvic pressure Pain in the back or legs Digestive problems such as gas, bloating, indigestion, long term stomach pain or feeling full quickly Having to urinate often or feeling like you have to “go� right away


Screening Research is being done to develop a screening test for ovarian cancer, but currently no standard exists. However, there are tests that might be helpful to some women. For example, women with strong family history of the disease may be screened with transvaginal sonography and blood tests.

Treatment If a woman is suspected to have ovarian cancer, her physician may refer her to an oncologist for additional testing. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more

For more information, visit MDOnc.com

The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.


PROSTATE CANCER FACTS

Prostate cancer is the second leading cause of cancer death for men in the United States. However, early detection can significantly improve the chances of survival.

Risk factors Age: The majority is found in men over the age of 65 Family history: There is an increased risk when immediate family members have the disease Diet: A diet including a lot of red meat and/or high-fat dairy products can yield a greater risk Exercise: Men who do not regularly exercise may have increased risk Race: African American men have greater incidence and death rates Nationality: Prostate cancer occurs more in North America

Signs and symptoms Usually, the early stages of prostate cancer are without obvious symptoms. However, any of the symptoms listed below should be discussed with a physician. Impotence Blood in urine Pain in the spine, hips, ribs or other bones Weakness or numbness in the legs or feet Loss of bladder or bowel control


Screening Screening tests can determine the presence of abnormal cells in the prostate. Beginning at age 50, men should have yearly screening exams, which include: Prostate-Specific Antigen (PSA) test, which screens blood for traces of PSA Digital Rectal Exam (DRE), which allows a doctor to physically examine the prostate for any lumps or hard places

Treatment If abnormal cells are present, the patient will be referred to an oncologist who will conduct a biopsy and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more

For more information, visit MDOnc.com

The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.


BREAST CANCER FACTS Breast cancer is a malignant tumor that develops from cells in the breast. It is the second leading cause of cancer death among women in the United States.

Risk factors Age: Most breast cancers develop in adults over the age of 50 Family history: The chance of developing breast cancer increases when immediate family members have had the disease Personal history: Women who had cancer in one breast have an increased risk of developing cancer in another area of that same breast or in the other breast Reproductive history: Women who began menstruating before 12 or experienced menopause after 55 may have an increased risk Alcohol: Consumption of alcohol can slightly increase a woman’s chance of developing breast cancer Weight: Being overweight is linked to a higher risk of breast cancer

Signs and symptoms Patients experiencing any of these symptoms should consult a physician. Abnormal swelling of a part of the breast Skin irritation or dimpling Nipple pain, nipple turning inward or abnormal discharge Redness or scaliness of the nipple or breast skin Lump in the underarm


Screening To diagnose and classify breast cancer, a physician may conduct the following screenings to improve the chances that the disease can be found and treated successfully at an early stage: Mammograms, which should be performed each year for women age 40 and older Clinical breast exams, women in their 20s and 30s should have a clinical breast exam every 3 years, and women over the age of 40 should have the exam every year

Treatment If cancer is suspected, the patient will be referred to an oncologist who will conduct tests and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more

For more information, visit MDOnc.com

The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.


Columbia

10710 Charter Drive, Suite G020 Columbia, MD 21044 Phone: 410-964-2212

Owings Mills

23 Crossroads, Suite 340 Owings Mills, MD 21117 Phone: 410-581-2100 Fax: 410-581-2104

Silver Spring

2101 Medical Park Drive Silver Spring, MD 20902 Phone: 301-933-3216

Help Us Know Your Medications A Personal Pocket Medication Card

Owings Mills & Gettysburg Mohit Narang, M.D. Robert L. Rice, M.D., Ph.D Silver Spring Kashif Ali, M.D. Alida Espinoza, M.D. Kashif Firozvi, M.D. Frederick Min, M.D.

Greenbelt

7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800

Laurel

7350 Van Dusen Road, Suite 370 Laurel, MD 20707 Phone: 301-982-9800

Greenbelt Thomas A. Bensinger, M.D., F.A.C.P. Martin D. Weltz, D.O., F.A.C.P., M.B.A., M.P.H

Gettysburg

40 V Twin Dr., Suite 104 Gettysburg, PA 17325 Phone: 717-338-9009 Fax: 717-334-1514

Columbia Jon K. Minford, M.D. Nicholas W. Koutrelakos, M.D. Clement B. Knight, M.D., MRCP, MRCPath Edward J. Lee, M.D. Tejaswi R. Sastry M.D. Adam Schmuckler, P.A.-C., MMSc

www.mdonc.com

Laurel Thomas A. Bensinger, M.D., F.A.C.P. Martin D. Weltz, D.O., F.A.C.P., M.B.A., M.P.H

Patient Information Name Phone Allergies

Primary/Family Physician Name Phone

Pharmacy Name Phone

Specialist Name Phone


Drug Name/Reason For Use

Dosage/Strength

How Often/Times Taken

Over the Counter Medications/ Vitamins/Herbals

Review with your doctor and pharmacist • Keep an up to date list of medications • Keep with you at all times • Reduces confusion and saves time • Improves MEDICATION SAFETY


Maryland Oncology Hematology

Kashif Ali, M.D. Dr. Kashif Ali earned his MD Degree from Ross University School of Medicine. He completed his residency in Internal Medicine at the Seton Hall University in New Jersey. While at Seton Hall University he became the Chief Resident and then went on to complete his training in Hematology and Oncology. During this training he was appointed Chief Fellow. Dr. Ali is presently board certified in Internal Medicine, Hematology and Oncology. Dr. Ali is available to see patients in Hematology and Oncology.

Dr. Ali’s office locations: Laurel

Silver Spring

7350 Van Dusen Road, Suite 370

2101 Medical Park Drive, Suite 200

Laurel, MD 20707

Silver Spring, MD 20902

Phone: 301-982-9800

Phone: 301-933-3216

Greenbelt 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800 For more information, please visit www.MDOnc.com.

The Knowledge to Heal. The Compassion to Care.


IS CANCER IN YOUR GENES? Find out if you are at an increased risk for cancer.

Hereditary Cancer Risk and Assessment Program What is genetic testing? Today, tests are available that will find some cancer-related genes in the human body. Gene testing can determine if you have or do not have a disease-related gene condition that may put you at higher risk of getting cancer before any symptoms appear.

Who should consider genetic counseling/testing? Some people are at higher risk of developing certain types of cancer because they have an inherited gene condition. If you have been diagnosed with cancer before the age 50, have multiple family members with the same type of cancer or have experienced multiple cancers, you may want to speak with your physician about genetic counseling.

Why is genetic testing important? Although genetic testing cannot predict whether you will actually develop cancer, understanding your risk of developing the disease can be an important step in making lifestyle decisions that can help prevent cancer or about getting regular screenings that can detect cancer early, when it is most treatable.

Consider scheduling an appointment with Maryland Oncology Hematology if you or a family member have: Breast Cancer under age 50 Bilateral Breast Cancer Ovarian Cancer at any age Male breast cancer in patient or family member Ashkenazi Jewish Ancestry with Personal or Family History of Breast and/or Ovarian Cancer

More than 3 Family Members with Breast and/or Ovarian Cancer

More than 2 Family Members with Premenopausal

Breast and/or Ovarian Cancer at any age

About the Hereditary Risk and Assessment Program As part of our comprehensive cancer care services, Maryland Oncology Hematology provides an in-depth cancer risk assessment for individuals with a significant personal and/or family history of cancer. Our physicians provide information and support to patients

Call to schedule an appointment:

and their families by:

• educating you about how genetics plays a part in cancer risk;

COLUMBIA (410) 964-2212

• assessing your risk of a genetic disorder by researching your family’s history and evaluating medical records;

• discussing the medical, social and ethical impact of genetic testing on you and your family;

• interpreting genetic testing results and medical data; and • explaining possible treatments or preventive measures. 10710 Charter Drive, Suite G020 • Columbia, MD 21044 Learn more at

mdonc.com


Comprehensive care close to home. Services Every cancer is different, and so is every person. That’s why we offer a full range of treatments and support services that can be tailored to your individual needs. Most cancer treatments do not require hospitalization, and can be performed in our outpatient infusion room. Maryland Oncology’s state-of-the-art facilities, staffed by experience physicians and specially trained oncology nurses, provide injections, infusions, chemotherapy, antibiotics and other medication to patients in a comfortable and friendly setting. • Physician evaluation and treatment planning for blood disorders and cancer care • Chemotherapy and infusion therapy • Administration of injections for the treatment of cancer and hematologic disorders • Therapeutic phlebotomies • Laboratory services by a state accredited lab

Clinton

8926 Woodyard Road, Suite 101 Clinton, MD 20735 301-868-7911

Physicians and Services

Columbia

10710 Charter Drive, Suite G020 Columbia, MD 21044 410-964-2212

Since 1986, Maryland Oncology Hematology has made important contributions to the fight against cancer and diseases of the blood by offering a full range of treatment options and support services, as well as clinical research trials to our patients and their families. Maryland Oncology Hematology also provides access to resources typically found only in major academic medical centers and large hospital systems, along with the personal touch and compassion that you would expect to find from your community physician. And because of our integrated, team-based approach to patient care, we work closely with our patients and their families to create an individual treatment plan that cares for their physical and emotional health. Best of all, this entire comprehensive plan is delivered in a familiar setting, close to home.

Greenbelt

7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 301-982-9800

Lanham

8116 Good Luck Road, Suite100 Lanham, MD 20706 301-474-0427

Laurel

7350 Van Dusen Road, Suite 370 Laurel, MD 20707 301-982-9800

Sliver Spring

12210 Plum Orchard Drive, Suite 211 Silver Spring, MD 20904 301-933-3216

Wheaton

2730 University W Blvd., Suite 400 Wheaton, MD 20902 301-942-9220

Maryland Oncology Hematology is an affiliate of The US Oncology Network, one of the nation’s

• Bone marrow biopsies

largest community-based cancer treatment and

• Maintenance of IV devices

research networks focused on advancing cancer

• Access to complementary and alternative medicine

care in America. As an affiliate of The US Oncology Network, Maryland Oncology Hematology is united with approximately 1,000 physicians

• Second opinion services

mdonc.com

The Knowledge to Heal. The Compassion to Care.

nationwide. Maryland Oncology Hematology

participates in clinical trials through US Oncology Research, which has helped to develop 48 FDA approved cancer therapies.


Medical O ncology & Hematology Kashif Ali, M.D.

Medical School: Ross University School of Medicine Residency: Seton Hall University Fellowship: Seton Hall University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Silver Spring and Laurel

Kashif Firozvi, M.D.

Medical School: Georgetown University School of Medicine Residency: Georgetown School of Medicine Fellowship: Georgetown’s Lombardi Cancer Center Board Certifications: Medical Oncology Location: Silver Spring

Edward J. Lee, M.D.

Jun Sun, M.D.

Medical School: State University of New York Downstate Medical College Residency: Baltimore City Hospital Fellowship: University of Maryland Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia

Medical School: State University of New York at Buffalo School of Medicine Residency: Georgetown University Hospital Fellowship: Georgetown University Hospital/ Lombardi Cancer Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Cheryl A. Aylesworth, M.D.

Ari D. Fishman, M.D.

Jose Mendoza, M.D., F.A.C.P.

Deepnarayan Tiwarri, M.D.

Thomas A. Bensinger, M.D., F.A.C.P.

Rita Gupta, M.D., F.A.C.P.

Frederick Min, M.D.

Nikolaos Trikalinos, M.D.

Linda M. Burrell, M.D.

David J. Haidak, M.D., F.A.C.P.

Jon K. Minford, M.D.

Medical School: Tufts University School of Medicine Residency: Walter Reed Army Medical Center Fellowship: Walter Reed Army Medical Center Board Certifications: Internal Medicine and Medical Oncology Location: Wheaton

Medical School: George Washington School of Medicine Residency: Walter Reed Army Medical Center Fellowship: Duke University Medical Center and City of Hope National Medical Center Board Certifications: Internal Medicine and Hematology Location: Greenbelt Medical School: State University of New York Upstate Medical Center Residency: Walter Reed Army Medical Center Fellowship: Walter Reed Army Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Wheaton

Nicholas A. DeMonaco, M.D.

Medical School: Temple University School of Medicine Residency: University of Pittsburgh Fellowship: University of Pittsburgh Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Alida Espinoza, M.D.

Medical School: Central University of Venezuela Residency: Union Memorial Hospital Fellowship: University of Maryland Greenebaum Cancer Center Board Certification: Medical Oncology Locations: Silver Spring and Greenbelt

Medical School: Tel Aviv University Residency: Albert Einstein College of Medicine Fellowship: Montefiore Medical Center, Albert Einstein Comprehensive Cancer Center at Albert Einstein College of Medicine Board Certification: Internal Medicine, Medical Oncology and Hematology Locations: Wheaton and Greenbelt Medical School: Gandhi Medical College of Bhopal University Residency: Prince George Hospital Center Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Medical School: Albany Medical College Residency: Georgetown University Hospital and D.C. General Hospital Fellowship: Georgetown University Hospital and George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology, and Hematology Locations: Clinton and Lanham

Medical School: San Marcos National Major University Medical School Residency: The Washington Hospital Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Medical School: Cornell Residency: Cornell Fellowship: NIH and Georgetown University Medical Center Board Certifications: Internal Medicine and Medical Oncology Location: Silver Spring

Medical School: University of Pittsburgh School of Medicine Residency: New York University Medical Center Fellowship: National Cancer Institute Board Certifications: Internal Medicine and Medical Oncology Location: Columbia

Harvey I. Katzen, M.D., F.A.C.P.

Mohit Narang, M.D.

Nicholas W. Koutrelakos, M.D.

Tejaswi R. Sastry, M.D.

Medical School: George Washington Medical Center Residency: George Washington University Hospital Fellowship: George Washington University Hospital Board Certifications: Internal Medicine and Medical Oncology Locations: Clinton and Lanham

Medical School: University of Maryland Residency: University of Massachusetts, Berkshire Medical School Fellowship: Brown University Board Certifications: Medical Oncology Location: Columbia

Medical School: Dayanand Medical College Residency: Christ Hospital Fellowship: Michigan State University Board Certifications: Internal Medicine and Medical Oncology Locations: Columbia

Medical School: Kempegowda Institute of Medical Services Residency: University of North Carolina at Chapel Hill, Moses Cone Health Systems Fellowship: Eastern Carolina University Brody School of Medicine Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia

Medical School: Howard University College of Medicine Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Medical School: University of Ioannina Medical School Residency: MetroWest Medical Center Fellowship: University of Maryland’s Greenebaum Cancer Center Board Certification: Internal Medicine Locations: Clinton and Lanham

P hysician Extenders Adam Schmuckler, P.A.-C., MMSc College: Syracuse University Graduate School: Emory University Location: Columbia

Kristin Sorensen, FNP-C

College: Syracuse University Graduate School: University of Maryland Location: Silver Spring


WE ARE MAKING A CHANGE

New name. Same great care. Dr. Ari Fishman is joining the highly skilled physician team of Maryland Oncology Hematology to provide patients high-quality cancer care closer to home. Maryland Oncology Hematology, is committed to providing convenient, compassionate and cutting-edge hematology and oncology care to patients in our community. Dr. Fishman will be practicing at Maryland Oncology Hematology’s Silver Spring and Greenbelt locations.

Please ask your care provider or the front desk for more information on this exciting news.


Maryland Oncology Hematology UPDATE Summer 2013

OUR PHYSICIANS Kashif Ali, M.D. Manoj Agarwal, M.D., M.B.A. Cheryl Aylesworth, M.D. Thomas A. Bensinger M.D., F.A.C.P. Linda Burrell, M.D. Roopa De Chowdhury, M.D. Nicholas A. DeMonaco M.D. Alida Espinoza, M.D. Kashif Firozvi, M.D. Rita Gupta, M.D., F.A.C.P. David J. Haidak, M.D., F.A.C.P. Harvey I. Katzen, M.D., F.A.C.P. Nicholas W. Koutrelakos, M.D. Edward J. Lee, M.D. Jose Mendoza, M.D., F.A.C.P. Frederick Min, M.D. Jon K. Minford, M.D. Mohit Narang, M.D. Robert L. Rice, M.D., Ph.D. Tejaswi R. Sastry M.D. Jun Sun, M.D. Deepnarayan Tiwarri, M.D. Kai-Yiu Yeung, M.D., F.A.C.P. Ayana Elliott DNP, MS, APRN, F.N.P.-C. Adam Schmuckler P.A.-C., MMSc Kristin Sorensen N.P.-C., MS, R.N.

Oncology-Hematology Associates and Maryland Oncology Hematology Unite to Provide Expanded Quality Care Maryland Oncology Hematology is pleased to announce that Oncology-Hematology Associates, P.A. has joined its practice, expanding and enhancing patient services as well as adding additional treatment locations in Clinton and Lanham, MD. The eight board-certified physicians of Oncology-Hematology Associates joined Maryland Oncology Hematology’s group of 15 oncologists to offer state-of-the-art, comprehensive cancer care to oncology and hematology patients in the comfort and convenience of a patient-centered community setting. “We are pleased to welcome the physicians of Oncology-Hematology Associates to our practice,” said Jon Minford, M.D., medical oncologist and founder of Maryland Oncology Hematology. “Our collaboration with this team of like-minded, highly trained cancer specialists will allow us to expand and enhance our treatment model of providing high quality integrated, evidence-based cancer care and clinical research. Additionally, our patients will now have access to care in two more convenient locations in Maryland.” Together, Oncology-Hematology Associates and Maryland Oncology Hematology provide expanded service offerings to Clinton and Lanham, MD with the addition of Drs. David J. Haidak, Kai-Yiu Yeung, Harvey I. Katzen, Rita Gupta, Deepnarayan Tiwarri, Nicholas A. DeMonaco, Jose L. Mendoza and Jun F. Sun. Featured physicians left to right: Top Row Dr. DeMonaco, Dr. Sun, Dr. Katzen, Dr. Tiwarri Bottom Row Dr. Mendoza, Dr. Haidak, Dr. Yeung, Dr. Gupta

mdonc.com


Meet Our New Physician Team Members NICHOLAS A. DEMONACO M.D. Medical School: Temple University School of Medicine

OUR LOCATIONS

Residency: University of Pittsburgh

CLINTON 8926 Woodyard Road, Suite 101 Clinton, MD 20735 301-868-7911

Board Certifications: Internal Medicine, Medical Oncology and Hematology

Fellowship: University of Pittsburgh

Locations: Clinton and Lanham

RITA GUPTA, M.D., F.A.C.P. Medical School: Gandhi Medical College of Bhopal University Residency: Prince George Hospital Center Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

COLUMBIA 10710 Charter Drive, Suite G020 Columbia, Maryland 21044 410-964-2212

DAVID J. HAIDAK, M.D., F.A.C.P.

HARVEY I. KATZEN, M.D., F.A.C.P.

Medical School: Albany Medical College

Medical School: George Washington Medical Center

GETTYSBURG 40 V Twin Drive, Suite 104 Gettysburg, PA 17325 717-338-9009

Residency: Georgetown University Hospital and D.C. General Hospital

Residency: George Washington University Hospital

Fellowship: Georgetown University Hospital and George Washington University Medical Center

Fellowship: George Washington University

GREENBELT 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 301-982-9800

Board Certifications: Internal Medicine, Medical Oncology and Hematology

Board Certifications: Internal Medicine and Medical Oncology

Locations: Clinton and Lanham

Locations: Clinton and Lanham

LANHAM 8116 Good Luck Road, Suite100 Lanham, MD 20706 301-474-0427 LAUREL 7350 Van Dusen Road, Suite 370 Laurel, MD 20707 301-982-9800 PIKESVILLE 1838 Greene Tree Road, Suite 260 Pikesvlle, MD 21208 410-581-2100

JOSE MENDOZA, M.D F.A.C.P. Medical School: San Marcos National Major University Medical School Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

SILVER SPRING 2101 Medical Park Drive, Suite 200 Silver Spring, MD 20902 301-933-3216 WESTMINSTER 680 Poole Road, Suites A & B Westminster, MD 21157 410-581-2100 WHEATON 2730 University W Blvd., Suite 400 Wheaton, MD 20902 301-924-9220

Hospital

JUN SUN, M.D. Medical School: State University of New York at Buffalo School of Medicine Residency: Georgetown University Medical Center Fellowship: Georgetown University’s Lombardi Cancer Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

DEEPNARAYAN TIWARRI, M.D.

KAI-YIU YEUNG, M.D., F.A.C.P.

Medical School: Howard University College of Medicine

Medical School: National Taiwan University College of Medicine

Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Residency: Veterans Administration Hospital Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham


Maryland Oncology Hematology UPDATE Summer 2013

Kashif Ali, M.D.

Linda M. Burrell M.D.

Kashif Firozvi M.D.

Nicholas W. Koutrelakos, M.D.

Jon K. Minford M.D.

Jun Sun, M.D.

Manoj Agarwal M.D., M.B.A.

Roopa De Chowdhury, M.D.

Rita Gupta M.D., F.A.C.P.

Edward J. Lee M.D.

Mohit Narang M.D.

Deepnarayan Tiwarri, M.D.

Cheryl A. Aylesworth, M.D.

Nicholas A. DeMonaco M.D.

David J. Haidak M.D., F.A.C.P.

Jose Mendoza M.D., F.A.C.P.

Robert L. Rice M.D., Ph.D

Kai-Yiu Yeung M.D., F.A.C.P.

Thomas A. Bensinger M.D., F.A.C.P.

Alida Espinoza M.D.

Harvey I. Katzen M.D., F.A.C.P.

Frederick Min M.D.

Tejaswi R. Sastry M.D.

mdonc.com


2101 Medical Park Drive, Suite 200 Silver Spring, MD 20902

UNITED Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks dedicated to advancing cancer care and expanding patient access to high-quality care.

WE HEAL mdonc.com


Patient Binder

2101 Medical Park Drive, Suite 200 Silver Spring, MD 21044 Phone (301) 933-3216 Fax (301) 933-4941 www.mdonc.com

Kashif A. Firozvi, MD • Fredrick Min, MD • Alida Andriollo Espinoza, MD • Kashif Ali, MD • Kristin Sorensen-Tanenbaum, NP


PATIENT PLANNER B A S I C S F OR T HE N E WLY DIAGNOSE D

A PLANNER FOR PEOPLE WITH CANCER AND THEIR CAREGIVERS

www.MD ONC.c o m


Clinton 8926 Woodyard Road Suite 101 Clinton, MD 20735 Phone: 301-868-7911

Columbia 10710 Charter Drive Suite G020 Columbia, MD 21044 Phone: 410-964-2212

Gettysburg 40 V Twin Dr. Suite 104 Gettysburg, PA 17325 Phone: 717-338-9009

Greenbelt 7525 Greenway Center Dr. Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800

Lanham 8116 Good Luck Road Suite 100 Lanham, MD 20706 Phone: 301-474-0427

Laurel 7350 Van Dusen Road Suite 370 Laurel, MD 20707 Phone: 301-982-9800

Silver Spring 2101 Medical Park Drive Silver Spring, MD 20902 Phone: 301-933-3216

Wheaton 2730 University W. Blvd. Suite 400 Wheaton, MD 20902 Phone: 301-942-9220

Our mission is to deliver on the promise of providing the best patient care possible in a caring and supportive environment; with seamless access to the latest in technology and research available to help every patient live their highest quality of life.


OUR PHYSICIANS COLUMBIA Jon K. Minford, MD Nicholas W. Koutrelakos, MD Edward J. Lee, MD Mohit Narang, MD Tejaswi R. Sastry, MD

SILVER SPRING

Kashif Firozvi, MD Frederick Min, MD Alida Espinoza, MD Kashif Ali, MD Roopa DeChowdhury, MD

GREENBELT & LAUREL

PROVIDING COMPREHENSIVE, COMPASSIONATE CARE. Maryland Oncology Hematology provides patients with cutting-edge treatment options by a specialized team of board certified physicians. Our physicians have been recognized as Top Doctors by Baltimore Magazine, Washingtonian Magazine, and the US News & World Report. Our state of the art infusion centers offer services such as chemotherapy, laboratory testing, clinical trials and supportive care. The dedicated staff provide a full range of cancer care services.

For more information: www.mdonc.com

Thomas A. Bensinger, MD, FACP Alida Espinoza, MD Kashif Ali, MD Roopa DeChowdhury, MD

GETTYSBURG

Robert Rice, MD, PhD Mohit Narang, MD

CLINTON/LANHAM

David J. Haidak, MD, FACP Kai-Yiu Yeung, MD, FACP Harvey I. Katzen, MD, FACP Rita Gupta, MD, FACP Deepnarayan Tiwarri, MD Nicholas A. DeMonaco, MD Jun F. Sun, MD

WHEATON

Cheryl Aylesworth, MD Linda Burrell, MD

COLUMBIA (410) 964-2212

SILVER SPRING (301) 933-3216

GREENBELT (301) 982-9800

LAUREL (301) 982-9800

GETTYSBURG (717) 338-9009

WHEATON (301) 942-9220

CLINTON (301) 868-7911

LANHAM (301) 474-0427

1_13080996 VER31 MOH.indd 1

9/25/13 11:10 AM


TH E K N O W LE DGE T O HE AL . T H E C O M PA S S ION T O C A R E . Providing comprehensive, compassionate care to people challenged by cancer and blood disorders in the Prince George’s County area. David Haidak, MD, FACP Harvey Katzen, MD, FACP Rita Gupta, MD, FACP Deepnarayan Tiwarri, MD Nicholas DeMonaco, MD Jun Sun, MD Nikolaos Trikalinos M.D.

Clinton 8926 Woodyard Road, Suite 101 Clinton, MD 20735 301-868-7911 Lanham 8116 Good Luck Road, Suite 100 Lanham, MD 20706 301-474-0427

mdonc.com


Joining Forces in the Fight.

Maryland Oncology Hematology is pleased to announce the addition of Ari Fishman, M.D. to our physician staff.


E x p e rt P h y s i c i a n s . Exceptional Care.

At Maryland Oncology Hematology, we believe the best care is both advanced and compassionate. Our philosophy is to care for the whole person, not just fight the disease. We are proud to welcome Dr. Ari Fishman to our team of board certified physicians. Together, we will continue to provide patients with the latest cutting-edge treatments and options in their fight against cancer. Together with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks, Maryland Oncology Hematology is dedicated to expanding patient access to high-quality care. Dr. Fishman will see patients at our Greenbelt and Silver Spring Locations: GREENBELT 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800 SILVER SPRING 2730 University W. Blvd, Suite 400 Silver Spring, MD 20902 Phone: 301-942-9220 (Two Blocks from Wheaton Metro Station - Red Line)

Ari Fishman, M.D.

2730 University W. Blvd, Suite 400 Silver Spring, MD 20902


Joining Forces in the Fight.

Maryland Oncology Hematology is pleased to announce the addition of Ari Fishman, M.D. to our physician staff.


E x p e rt P h y s i c i a n s .E x c e p t i o n a l C a r e . At Maryland Oncology Hematology, we believe the best care is both advanced and compassionate. Our philosophy is to care for the whole person, not just fight the disease. We are proud to welcome Dr. Ari Fishman to our team of board certified physicians. Together, we will continue to provide patients with the latest cutting-edge treatments and options in their fight against cancer. Together with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks, Maryland Oncology Hematology is dedicated to expanding patient access to high-quality care. Dr. Fishman will see patients at our Greenbelt and Silver Spring Locations: GREENBELT 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800

SILVER SPRING 2730 University W. Blvd, Suite 400 Silver Spring, MD 20902 Phone: 301-942-9220 (Two Blocks from Wheaton Metro Station - Red Line)

Ari Fishman, M.D.

Rockville

South Laurel

Silver Spring Potomac

Greenbelt

495

McLean

Columbia Heights

WASHINGTON Capitol Heights

Arlington Annandale

395

295

Alexandria 95

Suitland-Silver Hill


WE ARE PROUD TO ANNOUNCE OUR NEW

LOCATION

12210 Plum Orchard Dr., Suite 211

Silver Spring, MD 20904

12210 Plum Orchard Dr., Suite 211 | Silver Spring, MD 20904


Brain Cancer Facts Primary brain tumors can start in almost any type of tissue or cell in the brain or spinal cord. Unlike cancers that start in other parts of the body, tumors that start in the brain or spinal cord rarely spread to distant organs, instead they cause damage by growing and destroying normal brain tissue. In 2013, about 23,130 malignant tumors of the brain or spinal cord are expected to be diagnosed in the United States. Overall, the chance that a person will develop a malignant tumor of the brain or spinal cord in his or her lifetime is less than 1% (about 1 in 140 for a man and 1 in 180 for a woman). Estimated New Brain Cancer Cases and Deaths 2007-2013 25,000 20,000 15,000 New Cases

10,000

Deaths

5,000 0

American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013.

Risk Factors

Signs and Symptoms

There are several factors that may increase the likelihood of

Tumors in any part of the brain may cause the intracranial pressure

developing brain tumors including:

to rise. This can be caused by growth of the tumor itself, swelling

Radiation exposure : The best known environmental risk factor for

brain tumors is radiation exposure, most often from some type of radiation therapy.

in the brain, or a blockage in the flow of cerebrospinal fluid. This increased pressure can lead to symptoms such as: •

Headache

Nausea

to have many tumors that first occur when they are young.

Vomiting

Some of these families have well-defined disorders, such as

Blurred vision

Neurofibromatosis type 1 (NF1), Neurofibromatosis type 2 (NF2),

Balance problems

Tuberous sclerosis, Von Hippel-Lindau disease or Li-Fraumeni

Personality or behavior changes

Seizures

Drowsiness or even coma

Family history: Patients with familial cancer syndromes tend

syndrome. Immune system disorders: Patients with impaired immune systems

have an increased risk of developing lymphomas of the brain or spinal cord.

Sources: National Cancer Institute and American Cancer Society

www.MDOnc.com


Brain Cancer Facts Screening At this time there are no widely recommended tests used to screen for brain and spinal cord tumors. Most brain tumors are found when a person sees a doctor because of signs or symptoms they are experiencing. Doctors recommend, however, that patients with certain inherited syndromes that put them at higher risk for brain tumors, such as neurofibromatosis or tuberous sclerosis, obtain

THE KNOWLEDGE TO HEAL. THE COMPASSION TO CARE. For over 20 years, Maryland Oncology Hematology has provided comprehensive, compassionate care to patients facing cancer and blood disorders in the Maryland area. Our team of experienced physicians, oncology certified nurses, and staff guides patients and their families through the latest advancements in treatment

frequent physical exams and other tests beginning at a young age.

options. Maryland Oncology Hematology offers a full range of

Staging

trials and support services all conveniently located in a familiar

personalized chemotherapy services, laboratory testing, clinical community setting.

If cancer is found, a physician will need to determine the progression of the cancer. This classification, called staging, allows the healthcare provider to properly identify a treatment plan and to determine the prognosis. All cancers are staged on a roman numeral scale, of I-IV (1-4), where the higher stage represents more advanced cancer.

Cheryl Aylesworth, MD Thomas Bensinger, MD, FACP Frederick Min, MD Linda Burrell, MD Roopa De Chowdhury, MD Alida Espinoza, MD Kashif Firozvi, MD Kashif Ali, MD Kristin Sorensen, FNP-C

Greenbelt • Laurel • Silver Spring • Wheaton To learn more or to refer a patient, visit www.MDOnc.com


ESOPHAGEAL CANCER FACTS There are two main types of cancer of the esophagus. One type grows in the cells that form the inside layer of the lining of the esophagus. This cancer is called squamous cell carcinoma and accounts for less than half of all cancers of the esophagus. The other type starts in the gland cells and is called adenocarcinoma. About 17,990 new esophageal cancer cases were diagnosed in the last year and 15,210 deaths were attributed to the disease. Esophageal cancer is three to four times more common among men than women with the lifetime risk of developing esophageal cancer in the United States about 1 in 125 for men and about 1 in 435 for women.

20,000

Estimated New Esophageal Cancer Cases and Deaths 2007-2013

15,000 New Cases

10,000

Deaths

5,000 0

American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013.

Risk Factors There are several factors that may increase the likelihood of developing esophageal cancer including: Age: The chance of developing esophageal cancer is low at younger

ages and increases with age. Less than 15 percent of cases are found in people younger than 55. Gender: Men have a three-fold higher risk of developing esophageal

cancer than women. Gastroesophageal reflux disease (GERD): Patients with GERD

have a higher risk of getting adenocarcinoma of the esophagus. The risk goes up based on how long GERD has been present and how severe the symptoms are. GERD can also cause Barrett’s esophagus, which is linked to an even higher risk. Barrett’s esophagus: Barrett’s esophagus increases the risk

of adenocarcinoma of the esophagus and the development of esophageal cancer. Tobacco and alcohol: The use of tobacco products, including

cigarettes, cigars, pipes, and chewing tobacco, is a significant risk

Sources: National Cancer Institute and American Cancer Society

factor for esophageal cancer, and the risk increases with increased use. Drinking alcohol also increases the risk of esophageal cancer, and combining smoking and drinking alcohol raises the risk of esophageal cancer much more than using either alone. Obesity: People who are overweight or obese have a higher chance of having esophageal reflex and getting adenocarcinoma of the esophagus. Diet: A diet high in processed meat, overeating and drinking very hot liquids frequently may increase the chance of developing esophageal cancer. A diet high in fruits and vegetables, however, is linked to a lower risk of esophageal cancer. Achalasia: Patients with achalasia have an increased risk of

esophageal cancer. On average, the cancer is often found 15-20 years after the achalasia is diagnosed. Tylosis: Patients with this rare, inherited disease have a very high

risk of getting squamous cell cancer of the esophagus and must be monitored closely for esophageal cancer.

www.MDOnc.com


ESOPHAGEAL CANCER FACTS Esophageal webs: About 1 in 10 patients with this syndrome eventually develop squamous cell cancer of the esophagus. Workplace exposures: Exposure to chemical fumes in certain

workplaces may lead to an increased risk of esophageal cancer. For example, exposure to the solvents used for dry cleaning may lead to a greater risk of esophageal cancer. Injury to the esophagus: Children who accidently swallow household cleaners containing lye and receive a severe chemical burn in the esophagus have an increased risk of developing squamous cell esophageal cancer as adults. History of certain other cancers: Patients who have had certain other cancers, such as lung cancer, mouth cancer, and throat cancer have a high risk of getting squamous cell carcinoma of the esophagus as well. Human papilloma virus: Genes from human papilloma virus (HPV)

have been found in up to one-third of esophagus cancer tumors from patients living in Asia and South Africa, but signs of HPV infection have not been found in esophagus cancers from patients living in the other areas, including the US.

Signs and Symptoms Esophageal cancers are usually found because of signs or symptoms a person is experiencing. If esophagus cancer is suspected, tests will be needed to confirm the diagnosis. Signs and symptoms of esophageal cancer include:

Screening In the United States, screening the general public for esophageal cancer is not recommended by any professional organization at this time, because no screening test has been shown to lower the risk of dying from esophageal cancer in people who are at average risk. However, people who have a high risk of esophageal cancer, such as those with Barrett’s esophagus, are often followed closely and have a regular upper endoscopy to look for early cancers and pre-cancers.

Staging If cancer is found, a physician will need to determine the progression of the cancer. This classification, called staging, allows the healthcare provider to properly identify a treatment plan and to determine the prognosis. All cancers are staged on a roman numeral scale, of I-IV (1-4), where the higher stage represents more advanced cancer.

Cheryl Aylesworth, MD Thomas Bensinger, MD, FACP Frederick Min, MD Linda Burrell, MD Roopa De Chowdhury, MD Alida Espinoza, MD

Trouble swallowing

Chest pain

Weight loss

Hoarseness

Chronic cough

Hiccups

Pneumonia

Bone pain

Bleeding into the esophagus

Kashif Firozvi, MD Kashif Ali, MD Kristin Sorensen, FNP-C

Greenbelt • Laurel • Silver Spring • Wheaton To learn more or to refer a patient, visit www.MDOnc.com


Oral Cavity & Oropharyngeal Cancer AWARENESS Oral cavity cancer occurs when cancer cells form in the mouth. Orophayngeal cancer begins in the oropharynx, the portion of the throat just beyond the mouth, which includes the base of the tongue, the soft palate, tonsils and the side and back walls of the throat. The American Cancer Society estimates that 36,000 new cases of cancer of the oral cavity and pharynx will be diagnosed in 2013 and that 6,850 oral cancer related deaths are expected to occur. Estimated New Oral Cavity & Oropharyngeal Cancer Cases and Deaths 2007-2013 45,000 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5,000 0

New Cases Deaths

Data pulled from the American Cancer Society, Cancer Facts and Figures 2007 – 2013.

Risk Factors

Signs and Symptoms

Tobacco and Alcohol: Tobacco and alcohol use are the strongest

Oral cavity and oropharyngeal cancer may be discovered during an

risk factors for oral cavity and oropharyngeal cancers. Studies have

oral exam by dentist or doctor but is typically diagnosed as a result

estimated the risk of developing these cancers in heavy drinkers and

of symptoms occurring:

smokers may be as much as 100 times more than the risk of these

Mouth sore that won’t heal

A lump or thickening in cheeks

White or red patches on the gums, tongue, tonsils, or lining of the mouth

Gender: Men are twice as likely to develop oral or oropharyngeal

Trouble chewing or swallowing

cancer than women.

Tongue numbness

Voice changes

Difficulty moving the tongue or jaw

Bad breath that doesn’t go away

Swollen jaw

Loosening of the teeth

Pain around the teeth or jaw

Weight loss

cancers in people who don’t smoke or drink. Human papilloma virus (HPV) infection: Human papilloma virus

DNA is now linked to about 2 out of every 3 oropharyngeal cancers.

Age: Most diagnoses of oral and oropharyngeal cancers occur after

the age of 55. Genetic syndromes: Individuals with fanconi anemia or

dyskeratosis congenita are at increased risk for developing oral cancer.

Source: American Cancer Society

www.MDOnc.com


Oral Cavity & Oropharyngeal Cancer AWARENESS Screening There are various ways to screen for oral cavity or oropharyngeal cancer. Each method may be used alone, or in combination. Medical history and physical exam: Physician will ask about

symptoms related to oral cancer and check for possible signs. Complete head and neck exam: A specialist will do a thorough

examination of the head and neck area checking for abnormalities. The exam will utilize mirrors or fiber-optic scopes to observe the lymph nodes and deeper portions of the neck. Panendoscopy: This exam is performed in an operating room

THE KNOWLEDGE TO HEAL. THE COMPASSION TO CARE. For over 20 years, Maryland Oncology Hematology has provided comprehensive, compassionate care to patients facing cancer and blood disorders in the Maryland area. Our team of experienced physicians, oncology certified nurses, and staff guides patients and their families through the latest advancements in treatment options. Maryland Oncology Hematology offers a full range of personalized chemotherapy services, laboratory testing, clinical trials and support services all conveniently located in a familiar community setting.

while the patient is under general anesthesia by using various types of endoscopes to examine the oral cavity, oropharynx, larynx, esophagus, trachea and bronchi. Biopsy: Tissue samples are observed under a microscope. Imaging tests: Allow for more detailed examination of the mouth

and throat.

Treatment There are many treatment options for oral cancer, including chemotherapy, radiation therapy and surgery. Each method may

Cheryl Aylesworth, MD Thomas Bensinger, MD, FACP Frederick Min, MD Linda Burrell, MD Roopa De Chowdhury, MD Alida Espinoza, MD Kashif Firozvi, MD Kashif Ali, MD Kristin Sorensen, FNP-C

be used alone, or in combination. Chemotherapy is the use of drugs to kill cancer cells. The

drugs are administered orally by pills or injected directly into the bloodstream. They travel throughout the body to reach cancer cells that may have spread beyond the point of origin. Radiation therapy is the use of high-energy rays to kill cancer

cells in the treatment area. It is mostly administered externally from a machine outside the body, similar to an x-ray, but for a longer period of time. Surgery treats the cancer by removing the cancerous tissue. The

type of surgery required depends on the stage of the cancer.

Staging If cancer is found, a physician will need to determine the progression of the cancer. This classification, called staging, allows the healthcare provider to properly identify a treatment plan and to determine the prognosis. All cancers are staged on a roman numeral scale, of I-IV (1-4), where the higher stage represents more advanced cancer.

Greenbelt • Laurel • Silver Spring • Wheaton To learn more or to refer a patient, visit www.MDOnc.com


SKIN Cancer FACTS People say the glow of a tan makes them look healthier, but tanning is actually the skin’s reaction to harmful UV ray exposure. Skin cancer is the most common form of cancer in the United States. In fact, it is estimated by the American Cancer Society that more than two million cases of skin cancer will be diagnosed this year. Indoor tanning is especially dangerous causing a 74% increased risk for melanoma, compared to those who have never used a tanning bed.1 There are three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Both basal cell and squamous cell carcinoma are highly treatable. Malignant melanoma is the most serious type of skin cancer and more likely to spread to other parts of the body.

Risk Factors

Signs and Symptoms

Exposure to sunlight: Exposure to UV radiation, either from the

Patients should check the pattern of moles, freckles and other marks

sun or tanning lamps increases risk for melanoma.

once a month and consult their healthcare provider if a mole or

Fair skin: People with fair skin, freckling or red or blond hair have a higher risk of melanoma.

growth worries them or has changed in size, shape or color. The ABCD rule can help distinguish a normal mole from melanoma:

Age: Chances of being diagnosed with skin cancer increase with age,

Asymmetry: One half of the mole does not match the other half. Border irregularity: The edges of the mole are ragged or notched. Color: The color of the mole is not the same all over. There may be

but skin cancer is also found in young people.

shades of tan, brown or black and sometimes patches of red,

Moles: Certain types of moles increase a person’s chance of getting melanoma.

Family history: Around 10 percent of people with melanoma have a close relative with the disease. This may be because the family tends to spend more time in the sun or because family members have

white or blue.

Diameter: The mole is wider than about ¼ inch.

fair skin, or both.

diagnosis

Immune suppression: People who have been treated with

If cancer is suspected, a physician will perform further tests, which

medicines that suppress the immune system have an increased chance

may include a skin biopsy. Types of skin biopsies include:

of developing melanoma.

Incisional and excisional biopsies remove a wedge of the skin

History of melanoma: People who have already had melanoma

to look at the deepest layers. An incisional biopsy removes only part

have a higher risk of getting it again. Gender: Men have a higher risk than women. Xeroderma pigmentation: People with this rare, inherited condition are at a greater risk of developing melanoma.

1

FDA Consumer Health Information, US Food and Drug Administration, May, 2010

of the tumor, while an excisional biopsy removes the entire tumor. Shave biopsy in which the doctor “shaves” off the top layers of skin. Punch biopsy in which a round tool cuts through all the layers of the skin and brings up a sample of tissue.

www.MDOnc.com


SKIN Cancer FACTS Treatment options are different for different types and stages of

THE KNOWLEDGE TO HEAL. THE COMPASSION TO CARE.

skin cancer, but may include chemotherapy, radiation therapy,

For over 20 years, Maryland Oncology Hematology has provided

or surgery. Each treatment option may be used alone or

comprehensive, compassionate care to patients facing cancer and

in combination.

blood disorders in the Maryland area. Our team of experienced

Chemotherapy is the use of drugs to kill cancer cells.

physicians, oncology certified nurses, and staff guides patients

Treatment

Topical chemotherapy is a medicine that is placed directly onto the skin. Systemic chemotherapy uses drugs taken by mouth or injected. This treatment can be used when the cancer has spread to other organs.

and their families through the latest advancements in treatment options. Maryland Oncology Hematology offers a full range of personalized chemotherapy services, laboratory testing, clinical trials and support services all conveniently located in a familiar community setting.

Radiation therapy is the use of high-energy rays to kill cancer cells in the treated area. It is usually administered from

Cheryl Aylesworth, MD

a machine outside the body. It may also be used after surgery

Thomas Bensinger, MD, FACP

to kill cancer cells that may remain after surgery. Surgery treatment for melanoma can include removal of the melanoma, amputation of a finger or toe, or removal of lymph nodes. Non-melanoma is most commonly treated with surgery, ranging from simple excisions to laser surgery, to lymph node surgery.

Frederick Min, MD Linda Burrell, MD Roopa De Chowdhury, MD Alida Espinoza, MD Kashif Firozvi, MD Kashif Ali, MD Kristin Sorensen, FNP-C

PREVENTION Seek shade, especially during midday hours Wear clothing to protect exposed skin Wear a hat with a wide brim to shade the face, head, ears, and neck Wear sunglasses that wrap around and block as close to 100% of both UVA and UVB rays as possible Use sunscreen with sun protective factor (SPF) 15 or higher, and both UVA and UVB protection Avoid indoor tanning

Greenbelt • Laurel • Silver Spring • Wheaton To learn more or to refer a patient, visit www.MDOnc.com


The Knowledge to Heal. The Compassion to Care Jon K. Minford, M.D.

Tejaswi R. Sastry, M.D.

Medical Oncology & Hematology

Medical Oncology & Hematology

Medical School: University of Pittsburgh School of Medicine Residency: New York University Medical Center Fellowship: National Cancer Institute Board Certifications: Internal Medicine and Medical Oncology Location: Columbia

Medical School: Kempegowda Institute of Medical Services Residency: University of North Carolina at Chapel Hill, Moses Cone Health Systems Fellowship: Eastern Carolina University Brody School of Medicine Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia

Nicholas W. Koutrelakos, M.D.

Mohit Narang, M.D.

Medical Oncology & Hematology

Medical School: Dayanand Medical College Residency: Christ Hospital Fellowship: Michigan State University Board Certifications: Internal Medicine and Medical Oncology Locations: Columbia and Gettysburg

Medical School: University of Maryland Residency: University of Massachusetts, Berkshire Medical School Fellowship: Brown University Board Certification: Medical Oncology Location: Columbia

Medical Oncology & Hematology

Robert L. Rice, M.D. Edward J. Lee, M.D. Medical Oncology & Hematology Medical School: State University of New York Downstate Medical College Residency: Baltimore City Hospital Fellowship: University of Maryland Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia

Medical Oncology & Hematology Medical School: University of Pittsburgh School of Medicine Residency: University Hospitals Case Medical Center Fellowship: Vanderbilt University Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia and Gettysburg

Adam Schmuckler, P.A.-C., MMSc College: Syracuse University Graduate School: Emory University Location: Columbia

COLUMBIA 10710 Charter Drive, Suite G020 • Columbia, MD 21044 Phone: (410) 964-2212 • Fax: (410) 964-0380

MDOnc.com


WE ARE PROUD TO ANNOUNCE OUR NEW

LOCATION

12210 Plum Orchard Dr., Suite 211 Silver Spring, MD 20904

MARYLAND ONCOLOGY HEMATOLOGY


W E H AV E A N E W

WHITE OAK ADDRESS

Burtonsville

Cloverly 200

Aspen Hill

95

Colesville 12210 Plum Orchard Dr #211

Bethesda

Wheaton

White Oak

Beltsville

495

Adelphi

BETHESDA

Silver Spring

College Park

Takoma Park

Maryland Oncology Hematology is pleased to announce we have opened a new office in White Oak. We remain committed to providing the best oncology and hematology services in a community setting close to home. Our new state of the art infusion center, offers today’s most effective therapies, expertly and compassionately delivered.

Our New Location

12210 Plum Orchard Dr., Suite 211 Silver Spring, MD 20904 To refer a patient, please call (301) 933-3216.

MDONC.COM


Maryland Oncology Hematology UPDATE Spring 2013

Our Physicians Kashif Ali, M.D. Manoj Agarwal, M.D., M.B.A. Cheryl Aylesworth, M.D. Thomas A. Bensinger M.D., F.A.C.P. Linda Burrell, M.D. Roopa De Chowdhury, M.D. Nicholas A. DeMonaco M.D., F.A.C.P. Alida Espinoza, M.D. Kashif Firozvi, M.D. Rita Gupta, M.D., F.A.C.P. David J. Haidak, M.D., F.A.C.P. Harvey I. Katzen, M.D., F.A.C.P. Nicholas W. Koutrelakos, M.D. Edward J. Lee, M.D. Jose Mendoza, M.D., F.A.C.P. Frederick Min, M.D. Jon K. Minford, M.D. Mohit Narang, M.D. Robert L. Rice, M.D., Ph.D. Tejaswi R. Sastry M.D. Jun Sun, M.D. Deepnarayan Tiwarri, M.D. Kai-Yiu Yeung, M.D., F.A.C.P. Ayana Elliott DNP, MS, APRN, F.N.P.-C. Adam Schmuckler P.A.-C., MMSc Kristin Sorensen N.P.-C., MS, R.N.

Oncology-Hematology Associates Joins Maryland Oncology Hematology Maryland Oncology Hematology is pleased to announce that Oncology-Hematology Associates, P.A. will join its practice, expanding and enhancing patient services as well as adding additional treatment locations in Clinton and Lanham, MD. Eight board-certified physicians will join Maryland Oncology Hematology’s group of 15 oncologists to offer state-of-the-art, comprehensive cancer care to oncology and hematology patients in the comfort and convenience of a patient-centered community setting. “We are pleased to welcome the physicians of Oncology-Hematology Associates to our practice,” said Jon Minford, M.D., medical oncologist and founder of Maryland Oncology Hematology. “Our collaboration with this team of like-minded, highly trained cancer specialists will allow us to expand and enhance our treatment model of providing high quality integrated, evidence-based cancer care and clinical research. Additionally, our patients will now have access to care in two more convenient locations in Maryland.” This merger with Oncology-Hematology Associates expands service offerings to Clinton and Lanham, MD with the addition of Drs. David J. Haidak, KaiYiu Yeung, Harvey I. Katzen, Rita Gupta, Deepnarayan Tiwarri, Nicholas A. DeMonaco, Jose L. Mendoza and Jun F. Sun. Featured physicians left to right: Top Row Dr. DeMonaco, Dr. Sun, Dr. Katzen, Dr. Tiwarri Bottom Row Dr. Mendoza, Dr. Haidak, Dr. Yeung, Dr. Gupta

mdonc.com


Meet Our New Physician Team Members Nicholas A. DeMonaco M.D., F.A.C.P. Medical School: Temple University School of Medicine

OUR LOCATIONS

Residency: University of Pittsburgh

Clinton 8926 Woodyard Road, Suite 101 Clinton, MD 20735 301-868-7911

Board Certifications: Internal Medicine, Medical Oncology, and Hematology

Fellowship: University of Pittsburgh

Locations: Clinton and Lanham

Rita Gupta, M.D., F.A.C.P. Medical School: Gandhi Medical College of Bhopal University Residency: Prince George Hospital Center Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Columbia 10710 Charter Drive, Suite G020 Columbia, Maryland 21044 410-964-2212

David J. Haidak, M.D., F.A.C.P.

Harvey I. Katzen, M.D., F.A.C.P.

Medical School: Albany Medical College

Medical School: George Washington Medical Center

Gettysburg 40 V Twin Drive, Suite 104 Gettysburg, PA 17325 717-338-9009

Residency: Georgetown University Hospital and D.C. General Hospital

Residency: George Washington University Hospital

Fellowship: Georgetown University Hospital and George Washington University Medical Center

Fellowship: George Washington University

Greenbelt 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 301-982-9800

Board Certifications: Internal Medicine, Medical Oncology, Hematology

Board Certifications: Internal Medicine and Medical Oncology

Locations: Clinton and Lanham

Locations: Clinton and Lanham

Lanham 8116 Good Luck Road, Suite100 Lanham, MD 20706 301-474-0427 Laurel 7350 Van Dusen Road, Suite 370 Laurel, MD 20707 301-982-9800 Pikesville 1838 Greene Tree Road, Suite 260 Pikesvlle, MD 21208 410-581-2100

Jose Mendoza, M.D F.A.C.P. Medical School: San Marcos National Major University Medical School Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Silver Spring 2101 Medical Park Drive, Suite 200 Silver Spring, MD 20902 301-933-3216 Westminster 680 Poole Road, Suites A & B Westminster, MD 21157 410-581-2100 Wheaton 2730 University W Blvd., Suite 400 Wheaton, MD 20902 301-924-9220

Hospital

Jun Sun, M.D. Medical School: State University of New York at Buffalo School of Medicine Residency: Georgetown University Medical Center Fellowship: Georgetown University’s Lombardi Cancer Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Deepnarayan Tiwarri, M.D.

Kai-Yiu Yeung, M.D., F.A.C.P.

Medical School: Howard University College of Medicine

Medical School: National Taiwan University College of Medicine

Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham

Residency: Veterans Administration Hospital Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham


Maryland Oncology Hematology UPDATE Spring 2013

Kashif Ali, M.D.

Linda M. Burrell M.D.

Kashif Firozvi M.D.

Nicholas W. Koutrelakos, M.D.

Jon K. Minford M.D.

Jun Sun, M.D.

Manoj Agarwal M.D., M.B.A.

Roopa De Chowdhury, M.D.

Rita Gupta M.D., F.A.C.P.

Edward J. Lee M.D.

Mohit Narang M.D.

Deepnarayan Tiwarri, M.D.

Cheryl A. Aylesworth, M.D.

Nicholas A. DeMonaco M.D., F.A.C.P.

David J. Haidak M.D., F.A.C.P.

Jose Mendoza M.D., F.A.C.P.

Robert L. Rice M.D., Ph.D

Kai-Yiu Yeung M.D., F.A.C.P.

Thomas A. Bensinger M.D., F.A.C.P.

Alida Espinoza M.D.

Harvey I. Katzen M.D., F.A.C.P.

Frederick Min M.D.

Tejaswi R. Sastry M.D.

mdonc.com


2101 Medical Park Drive, Suite 200 Silver Spring, MD 20902

UNITED Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks dedicated to advancing cancer care and expanding patient access to high-quality care.

WE HEAL mdonc.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.